Layer 1

Managing allergy during the COVID-19 pandemic


C+D spoke to allergy expert, Dr Elizabeth Angier, on the importance of improving allergy care in community pharmacy


C+D spoke to Dr Elizabeth Angier, a portfolio GP with an interest in allergy.

Dr Angier works across boundaries in hospitals, the community and commissioning. She was previously chair of the primary care group at the British Society of Allergy and Clinical Immunology (BSACI) and is the current chair of the European Academy of Allergy and Clinical Immunology (EAACI) working group in primary care.

You can listen to the podcast below. Alternatively, subscribe to C+D's podcasts on iTunes or by searching “Chemist+Druggist podcast” on your preferred Android podcast app.

In this first instalment, Dr Angier discusses the differential diagnosis between allergy and COVID-19. We discuss how symptoms in allergy and COVID-19 infection may overlap and how the two conditions can be confused.

Dr Angier tells us, “There seems to be an overlap of symptoms in the early stages, such as itching eyes, runny nose, blockage and sneezing – the usual presentation of allergy symptoms. However, if symptoms such as significant cough, fever, malaise, loss of smell or gastrointestinal symptoms appear, these may be more suggestive of COVID-19".

Now more than ever, the control of allergy symptoms is extremely important. Patients with COVID-19 with poor allergy control may be at greater risk of spreading the virus further and may also be at risk of more severe symptoms of COVID-19.

Dr Angier discusses the importance of allergen avoidance and treatments that can be recommended over-the-counter for those patients who are struggling to control their symptoms with avoidance methods.

This podcast has been developed in partnership with Piri – from the makers of Piriton.

For product information click here.

Login or register to post comments

Job of the week

Pharmacist Manager
Midlands, Cheshire & Dorset
Salary dependent upon experience